GPC1 and urinary bladder carcinoma: Recent studies in animal models and clinical studies in cancer patients resemble potential of using anti-GPC1 antibody for detection of bladder cancer using fluorescence imaging [38] or utilizing GPC-1 directed radioimmunotherapy in different solid tumors [39].